Lanean...
Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial
AIM: To assess the efficacy and safety of once‐daily ipragliflozin 50 mg versus placebo in Japanese people with type 1 diabetes mellitus (T1DM) inadequately controlled with insulin. MATERIALS AND METHODS: We conducted a multicentre, double‐blind, parallel‐group, placebo‐controlled phase 3 study. Par...
Gorde:
| Argitaratua izan da: | Diabetes Obes Metab |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Blackwell Publishing Ltd
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772182/ https://ncbi.nlm.nih.gov/pubmed/31173455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13807 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|